Balyasny Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-200,000
Closed -$1.09M – 3484
2026
Q1
$1.09M Buy
200,000
+150,000
+300% +$842K ﹤0.01% 2042
2025
Q4
$350K Sell
50,000
-50,000
-50% -$391K ﹤0.01% 2668
2025
Q3
$773K Buy
+100,000
New +$781K ﹤0.01% 2223
2022
Q4
– Sell
-43,100
Closed -$1.09M – 3231
2022
Q3
$1.09M Buy
+43,100
New +$1.51M ﹤0.01% 1760

Other funds holding TDOC

Balyasny Asset Management's TDOC Position: Q2 2026 in Review

Balyasny Asset Management reduced its Teladoc Health (TDOC) stake by 51% in Q2 2026, selling an estimated $295K and leaving 42,284 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Balyasny Asset Management first reported a position in TDOC in Q2 2018 and has held it in 23 quarters since. The position peaked at $43.2M in Q2 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Balyasny Asset Management held 42,284 shares of Teladoc Health worth $359K as of Q2 2026.
  • Balyasny Asset Management sold 44,354 Teladoc Health shares in Q2 2026, an estimated $295K.
  • Teladoc Health made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2656 holding.
  • Balyasny Asset Management first reported a position in Teladoc Health in Q2 2018 and has held it in 23 quarters since.
  • Balyasny Asset Management's Teladoc Health position peaked at $43.2M in Q2 2023.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.